Canada’s Rare Drug Program: A Boldacious Billion$ Investment Optimizing for Rare Drug Access
December 1 & 2, 2021 11am - 2pm ETFinal Agenda 12 Steps to Canada’s Rare Disease Drug Program
Vision: Integrated, Inclusive, Innovative Rare Drug System
Single Seamless Pathway from R&D, CT, regulatory approval, access parameters, monitoring, values-based assessment, price negotiations
Governance board representing all stakeholders: diverse patient community, clinical specialities, public/private drug plan providers, HTA agencies, pharmaceutical companies, subject matter experts (regulatory, research, )
Please contact us at info@raredisorders.ca for any questions about this event.